- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.
A health worker administers the COVISHIELD vaccine for COVID-19 at a Government Fever Hospital in Hyderabad, India, Thursday, 1 April 2021 - Sputnik International

Live Updates: India Registers 259,170 New COVID-19 Cases as Delhi Plunges Into Lockdown

Subscribe
The global death toll from the coronavirus infection has topped 3.024 million and over 141.6 million cases have been detected, according to Baltimore, Maryland's Johns Hopkins University, which tracks and compiles data from national and local authorities, the media and other sources.

The United States, India and Brazil lead in terms of the number of registered coronavirus infections; the largest number of COVID-19-related deaths has been observed in the United States, Brazil, Mexico and India, according to Johns Hopkins University.

On Monday, the Delhi government announced that the Indian capital would enter a week-long lockdown amid a steep rise in coronavirus cases in order to ease the pressure on the healthcare system and curb the spread of the virus. Shortly thereafter, the UK announced that India would be placed on the country's red list of destinations, subject to travel bans, due to the emergence of a new coronavirus variant. Prime Minister Boris Johnson has called off his trip to the South Asian country, which had been scheduled for next week.

Meanwhile, the United States will place about 80 percent of countries around the world on its "Do Not Travel" list this week, in line with official health guidance regarding the coronavirus pandemic.

Follow Sputnik’s feed to find out more.

Table of contents
New firstOld first
18:49 GMT 20.04.2021

About 11 million people got vaccinated with the Russian-made Sputnik V COVID-19 vaccine, Alexander Gintsburg, the head of the Gamaleya Institute that developed the vaccine, said on Tuesday.

"About 10-11 million have been vaccinated, and maybe even more, if you take into account foreign countries," Gintsburg said during his appearance on Channel One.

Sputnik V, the world's first registered COVID-19 vaccine, has been authorised for emergency use in 60 countries across the globe. According to an interim analysis from the trial published in The Lancet, the vaccine has 91.6 percent efficacy.

18:36 GMT 20.04.2021

The Netherlands on Wednesday will start inoculating its population with the COVID-19 vaccine developed by Janssen Pharmaceuticals, a European subsidiary of US company Johnson & Johnson, Dutch Health Minister Hugo de Jonge said on Tuesday.

Earlier in the day, the European Medicines Agency (EMA), the EU drug regulator, said that it found a "possible link" between the Johnson & Johnson COVID-19 vaccine and blood-clotting events with low platelets. It added that this side effect was rare and that the vaccine's overall benefits outweigh the risks.

"Vaccination with Janssen will begin tomorrow ... The EMA has carefully studied and reported that there were very few reported side effects. This means that the vaccine can be used as planned and we will start doing so tomorrow," de Jonge told reporters.

The vaccine was investigated after the US Food and Drug Administration and the Centers for Disease Control and Prevention recommended the suspension of the Johnson & Johnson vaccine after six cases of blood clots in combination with low levels of blood platelets were registered. The cases were confirmed in women between the ages of 18 and 48. In total, over 7 million people have been inoculated with this vaccine in the United States.

18:23 GMT 20.04.2021
17:26 GMT 20.04.2021
16:11 GMT 20.04.2021
A person receives a dose of the Johnson & Johnson coronavirus disease (COVID-19) vaccine during a visit of U.S. Vice President Kamala Harris to a vaccination center in Chinatown, in Chicago, Illinois, U.S., April 6, 2021 - Sputnik International, 1920
EMA Finds 'Possible Link' Between J&J Vaccine, Blood Clot Events With Low Platelets
15:54 GMT 20.04.2021
A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021.  - Sputnik International, 1920
EU Shortages of AstraZeneca Vaccine Blamed on Insufficient Production of Serum, Reports Say
14:52 GMT 20.04.2021

WASHINGTON (Sputnik) – An airline travel app will expand to include COVID-19 test results from Unilabs, the leading European diagnostic services provider, the International Air Transport Association (IATA) said on Tuesday.

“The agreement will make Unilabs one of the first major lab groups to be integrated into IATA’s Travel Pass app. Proof of a negative Covid-19 test is required by many governments as a condition of entry, and the app makes the process seamless, secure, and easy,” IATA said in a press release.

The IATA Travel Pass provides information on national entry requirements, directs travelers to trusted labs, and allows passengers to receive and manage digital certificates for COVID-19 tests and vaccinations, the release said.

The Travel Pass app allows travelers to document vaccine and test history with authorities at national borders and in airports, according to the release.

13:10 GMT 20.04.2021

The total volume of CoronaVac vaccines supplied by its developer China’s Sinovac Biotech has exceeded 260 million doses, 60% of them to other countries, Yin Weidong, the company’s president and chief executive officer, said on Tuesday.

"At this moment Sinovac has supplied over 260 million vaccine doses against COVID-19 globally, 60% of them — outside China," the president said at Boao Forum for Asia in Hainan as quoted by Chinese media.

He said that the company produces over 6 million doses every day, adding that 160 million CoronoVac shots have been administered worldwide.

According to Yin, Sinovac plans to select 10 countries to which it would transfer the vaccine’s technology for carrying out joint research.

In early April, the company said that it could increase the vaccine’s production to 2 billion doses a year after an additional production plant was put into operation. Over 30 countries have so far approved the emergency use of CoronaVac.

13:09 GMT 20.04.2021

The Italian federal government on Tuesday will hold a meeting with the regional administrations to discuss easing coronavirus restrictions countrywide scheduled to begin on 26 April, the ANSA news agency reported.

Before the meeting, the country's scientific and technical committee (CTS) is expected to decide on such measures as shifting the night curfew start from 10 p.m. (20:00 GMT) to 11 p.m. or to midnight, and the issue of vaccine passes.

Out of 20 regions, five of which are autonomous, 11 provinces and two autonomous areas of Trento and Bolzano expect to switch to the so-called yellow zone, which entails a low-to-moderate coronavirus incidence rate in the national color code to distinguish its regions. The scheme also includes red, orange and white colors. According to the latest data provided by the Health Ministry, most regions are currently in the orange zone. Three regions — Apulia, Sardinia, Aosta — are red. The country has neither yellow nor white regions.

According to earlier media reports, the government is expected to either lift lockdown measures for all economic facilities in yellow zones starting April 26 or begin the reopening of public places and entertainment venues in yellow areas from May 1, with the further resumption of operation for such facilities as gyms and swimming pools later in May.

According to the latest data provided by the health ministry, Italy has confirmed nearly 3.9 million COVID-19 cases and 117,243 related fatalities. To date, a total of 15,558,775 coronavirus vaccine shots have been administered in the country, of which 4,556,228 people have completed the vaccination course.

12:55 GMT 20.04.2021

"In view of the COVID-19 situation, it has been decided, in consultation with the EU and Portuguese leadership, to hold the India-EU Leaders’ Meeting in a virtual format on 8 May 2021," said the foreign ministry statement.

12:15 GMT 20.04.2021
12:04 GMT 20.04.2021

"People under the age of 65 who have already received a dose of Vaxzevria should instead be offered a second dose of so-called mRNA vaccine, such as PfizerBiontech or Moderna," the Health Agency said in a statement. 

11:30 GMT 20.04.2021

The European Commission has started consultations with the United States on mutual recognition of coronavirus certificates, a commission spokesperson announced on Tuesday.

"As we've already got in our proposal on the digital green certificates, third countries can be granted an adequacy decision. For us, it's important to work with other countries wherever their systems are compatible with our own. We've seen a lot of interest amongst other countries. A number of third countries have had contact with the commission on the subject and are interested, but as things stand, our priority is to make sure that it works within the European Union ... We are having contacts with the United States on the digital green certificate, and in particular, with respect to coherence and compatibility, where commission services have had initial technical exchanges with the United States," the spokesperson said at a press conference.

11:16 GMT 20.04.2021
10:30 GMT 20.04.2021

 The European Commission, with the help of Austria, will give an impetus to the inoculation campaigns in the Western Balkan nations by delivering 651,000 doses of the BioNTech/Pfizer coronavirus vaccine starting May, President Ursula von der Leyen said on Tuesday.

"We stand by our neighbours and partners in the Western Balkans in fighting the pandemic. With the support of Austria, we will deliver 651.000 doses of vaccines, funded by the EU, to the Western Balkans, as of May and until the end of August. We are in this together," von der Leyen wrote on Twitter.

The EU body said in a press release that Austria would facilitate the sharing of the coronavirus vaccine doses through legal arrangements with the drugmaker and its Western Balkan partners. The project will be funded from the package worth 70 million euros ($84.4 million) that the commission adopted last December to help cover the cost of vaccines, secured by the bloc for the Western Balkan nations.

10:27 GMT 20.04.2021

The Japanese government may soon consider declaring another state of emergency in the Osaka prefecture over a surge in coronavirus cases, NHK reported on Tuesday.

On Monday, Osaka Governor Hirofumi Yoshimura talked about asking the government to declare a state of emergency. The official also mentioned his plans to talk to his colleagues in Kyoto and Hyogo to have a joint request.

The issue may be discussed later in the day by Prime Minister Yoshihide Suga and relevant cabinet members, such as Yasutoshi Nishimura, the minister in charge of the country’s COVID-19 response, and Health Minister Norihisa Tamura.

In January, the Japanese government imposed a state of emergency in 11 prefectures — Tokyo, Kanagawa, Saitama, Chiba, Tochigi, Aichi, Gifu, Osaka, Kyoto, Fukuoka, and Hyogo — which was then extended until 7 March for all the prefectures except Tochigi. With the epidemiological situation improving, the central government lifted the state of emergency in six prefectures in late February but kept it in place in Tokyo, Saitama, Kanagawa and Chiba until 21 March.

10:26 GMT 20.04.2021

Amazon and Flipkart have suspended deliveries of non-essential items in Delhi due to the lockdown that the state government has imposed, owing to a massive surge in coronavirus cases.

The online marketplaces are still delivering essentials such as food and grocery products, health supplies, as well as personal care items in the capital city.

10:03 GMT 20.04.2021
In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.  - Sputnik International, 1920
South Korean Company to Begin Producing Russia's Sputnik V in May, Reports Say
09:49 GMT 20.04.2021
09:35 GMT 20.04.2021
08:20 GMT 20.04.2021

Russia's single-day coronavirus increase fell to the lowest level since September 28, as 8,164 new cases were confirmed, down from 8,589 the day before, the coronavirus response centre said on Tuesday.

Russia recorded 8,135 COVID-19 cases on 28 September 2020.

"Over the past day, 8,164 coronavirus cases were confirmed across 83 Russian regions, including 1,026 cases (12.6 percent) without clinical symptoms," the centre said, adding that the overall tally reached 4,718,854.

The rate of increase fell to 0.17 percent.

Moscow confirmed 1,996 new coronavirus cases over the past 24 hours, down from 2,279 the day before. The Russian capital was followed by St. Petersburg with 687 new cases, down from 692 the day before, and the Moscow Region with 562 new cases, down from 592 on Monday.

No new cases were registered in the Nenets Autonomous Region and the Chukotka Autonomous Region.

The response centre reported 379 COVID-19 fatalities, up from 346 the day before, raising the country's death toll to 106,307.

Total recoveries increased by 9,631 over the given period, up from 6,818 the previous day, and reached 4,343,229 in total.

08:18 GMT 20.04.2021
 A nurse prepares to use AstraZeneca coronavirus disease (COVID-19) vaccine - Sputnik International, 1920
AstraZeneca Vaccine May Be 'Less Effective' Against Indian Strain of COVID, Says UK Health Secretary
07:53 GMT 20.04.2021
07:52 GMT 20.04.2021
07:40 GMT 20.04.2021
06:31 GMT 20.04.2021

Mexico has extended the ban on crossing its land border from the United States for states considered high COVID-19 risk, the Mexican Ministry of Foreign Affairs said on Tuesday.

"[Mexico's] restrictions on non-essential land border crossing from [the United States] will be maintained until 23:59 of May 21 [04:59 May 22 GMT], 2021, in the northern states which are colored [orange] and [red], according to the epidemiological risk indicators of [the Mexican government]," the ministry tweeted.

This means that out of the country's five border states, the ban will remain in force only in Chihuahua.

"[Mexico] and [the United States] are discussing making border restrictions more flexible based on the spreading rate of COVID-19 on both sides of the border," the ministry added.

Both countries have been hit hard by the ongoing COVID-19 pandemic, with the US having over 31.7 million confirmed coronavirus cases, according to the Johns Hopkins University database, and Mexico reporting over 2.3 million cases.

Since 21 March 2020, the US and Mexico have maintained border crossing restrictions that allow only essential cargo traffic and travels for medicinal, educational or governmental purposes, as well as emergency visits.

05:21 GMT 20.04.2021

Mexico expects to receive two batches of Russia's Sputnik V coronavirus vaccine by the end of April, Mexican Deputy Health Secretary Hugo Lopez-Gatell said during a press conference broadcast on the government YouTube channel.

"To all who have received the vaccine [the first component of Sputnik V]: the second component is arriving this Wednesday... Next week... there will be another delivery," Lopez-Gatell said.

A full two-dose vaccination scheme has covered 3.92 million people in Mexico, most of them, 3.1 million, are the elderly, 789,000 are doctors. Another 7.32 million people have received one dose of the vaccine so far.

The immunization program for the Mexican population began at the end of December 2020 with the staff of coronavirus hospitals. For these purposes, the authorities use five different vaccines, which are purchased abroad or produced locally, receiving the active component from biolaboratories - Pfizer/BioNTech, Oxford/AstraZeneca, Sinovac, Cansino and Sputnik V.

According to the Mexican Health Secretariat, since the beginning of the COVID-19 epidemic, about 2.5 million people have gotten infected in the country, with 212,466 deaths. Currently, 25,201 people are sick.

04:46 GMT 20.04.2021
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала